Processing

Please wait...

Settings

Settings

Goto Application

1. JP2013231081 - TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II

Office
Japan
Application Number 2013162201
Application Date 05.08.2013
Publication Number 2013231081
Publication Date 14.11.2013
Grant Number 5792774
Grant Date 14.08.2015
Publication Kind B2
IPC
A61K 38/46
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 9/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61K 38/47
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
47acting on glycosyl compounds (3.2), e.g. cellulases, lactases
C12Y 302/0102
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
YENZYMES
302Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
0102Alpha-glucosidase (3.2.1.20)
A61P 21/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
21Drugs for disorders of the muscular or neuromuscular system
A61P 3/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
A61P 37/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
06Immunosuppressants, e.g. drugs for graft rejection
Applicants DUKE UNIV
デューク ユニバーシティ
Inventors CHEN YUAN-TSONG
チェン,ユアン-ツォン
Agents 小野 新次郎
小林 泰
竹内 茂雄
山本 修
泉谷 玲子
Priority Data 60/219,237 18.07.2000 US
Title
(EN) TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II
(JA) II型糖原病の治療
Abstract
(EN)

PROBLEM TO BE SOLVED: To provide a first effective means for treating an individual with glycogen storage disease type II.

SOLUTION: A pharmaceutical composition contains human acidic α-glucosidase in a container with a label including instructions for administration of the composition for treatment of glycogen storage disease type II.

COPYRIGHT: (C)2014,JPO&INPIT


(JA)

【課題】II型糖原病を有する個体を治療するための最初の有効な手段を提供すること。
【解決手段】II型糖原病の治療用組成物の投与のための指示書を含むラベルを有する容器内にヒト酸α−グルコシダーゼを含有してなる医薬組成物。
【選択図】なし